Multiple studies have recognized the efficacy of e-cigarettes for smoking cessation
With a success rate of 65% and no increased respiratory risk
A German study showed that e-cigarettes are significantly effective in smoking cessation, which is consistent with previous research results from scientific research institutions in the United Kingdom, the United States, Australia and other countries. In addition, a study in the United States showed that e-cigarettes do not increase the risk of respiratory symptoms.
Recently, Germany conducted a study on whether electronic cigarettes can effectively assist smoking cessation. The study, published in the German medical journal Deutsches Ärzteblatt, tracked 2,740 smokers aged 14 to 96 with big data and found that e-cigarettes are far more effective in quitting smoking than other methods.
The second study, conducted by 19 researchers of different nationalities and published in the National Library of Medicine, included 3,516 smokers in Australia, the United Kingdom, Canada, and the United States. The authors noted in the article that among all study participants, they were seven times more likely to use e-cigarettes to quit smoking than those who did not try e-cigarettes.
In fact, many international scientific research institutions have previously confirmed the effectiveness of e-cigarettes for smoking cessation. Back in 2016, a UK study confirmed that it was more effective in quitting smoking, and three years later Public Health England reported that it had “a quit success rate of between 59.7% and 74%”, the highest of all the alternatives.
US researchers also came to the same conclusion, the success rate of smoking cessation “65.1%”. In Australia, researchers mentioned that the average success rate of quitting smoking with e-cigarettes was 96% compared to quitting without help.
In addition, 22 researchers from several universities and research centers in the United States conducted a new study on the relationship between smoking and respiratory symptoms in adults. To do this, they recruited 16,295 adults from the Population Assessment of Tobacco and Health (PATH) Survey, which was jointly conducted by the National Institutes of Health and the FDA.
They grouped groups of people who used various product types (cigarettes, cigars, hookahs, e-cigarettes, etc.). The conclusions drawn from the data study show that, with the exception of e-cigarettes, people who use all types of products, including cigarettes, have a higher risk of respiratory symptoms. In most cases, those who exclusively use e-cigarettes did not cause an increased respiratory risk.